Sanofi (SNYNF – Research Report) received a Buy rating and price target from DZ BANK AG analyst Elmar Kraus today. The company’s shares closed yesterday at $108.00. According to TipRanks ...

DZ Bank upgraded Sanofi (SNY) to Buy from Hold with a EUR 122 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See ...

Also Read: Sanofi’s Blood Cancer Drug’s New Subcutaneous Formulation Hits Primary Goal In Late-Stage In Multiple Myeloma The facility’s quality unit was also scrutinized for its inability to ...

Keys has beaten Elena Rybakina and Elina Svitolina to reach her third Australian Open semi-final. Both women’s semi-finals will be played in the night session on Rod Laver Arena on Thursday ...

French pharmaceutical giant Sanofi has received a warning letter from the U.S. Food and Drug Administration following an inspection at its drug manufacturing facility in Framingham. French ...

Should Swiatek reach the final - and top seed Sabalenka lose her semi-final on Thursday - the 23-year-old would regain the world number one ranking. If both players advanced to a mouth-watering ...

Professional tennis can be a lonely pursuit, a results-orientated business that can be hard to deal with, especially when injuries occur. But sometimes out of the depths of despair comes salvation. In ...

Jannik Sinner emphatically ended local hopes of a first home men’s singles champion since 1976 by easing past Alex de Minaur with a polished quarterfinal performance on Wednesday night at Australian ...

The records keep on coming for Novak Djokovic. After defeating Carlos Alcaraz in a pulsating Australian Open quarter-final, Djokovic became the first man in history to reach a 50th Grand Slam ...

Sanofi’s (NASDAQ:SNY) consumer healthcare unit Opella announced Tuesday that the U.S. FDA has lifted a clinical hold on a trial designed to test an over-the-counter version of its erectile ...

Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a U.S. drug ingredients plant tied to its longstanding subsidiary Genzyme.

In 2014, Lilly inked a licensing agreement with Sanofi that allows the latter company to pursue regulatory approval of OTC Cialis in the U.S., Europe, Canada and Australia.